Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic

Minkook Seo1, Yangsean Choi2, Youn Soo Lee3

  • 1Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

PubMed
Abstract

Insights

Dynamic susceptibility contrast (DSC) and dynamic contrast-enhancement (DCE) MRI, MR spectroscopy (MRS), and diffusion-weighted imaging (DWI) can help differentiate high-grade gliomas (HGGs) from low-grade gliomas (LGGs). The 95th percentile of relative cerebral blood volume (rCBV) is most effective for this distinction.

Area of Science:

  • Neuroimaging
  • Oncology
  • Radiology

Background:

  • Accurate differentiation between high-grade gliomas (HGGs) and low-grade gliomas (LGGs) is crucial for appropriate patient management and treatment planning.
  • Advanced MRI techniques offer potential for non-invasive assessment of glioma biology and grade.
  • Identifying specific imaging biomarkers can improve diagnostic accuracy and guide therapeutic strategies.

Purpose of the Study:

  • To evaluate the diagnostic performance of dynamic susceptibility contrast (DSC), dynamic contrast-enhancement (DCE), MR spectroscopy (MRS), and diffusion-weighted imaging (DWI) in distinguishing HGGs from LGGs.
  • To assess the utility of these advanced MRI techniques in predicting IDH mutation status in diffuse gliomas.

Main Methods:

  • Retrospective analysis of 72 patients with pathologically confirmed gliomas (16 LGGs, 56 HGGs).
  • Histogram analysis of relative cerebral blood volume (rCBV), volume transfer constant (Ktrans), and apparent diffusion coefficient (ADC) from segmented tumors.
  • Calculation of choline-to-creatinine ratio (Cho/Cr) using MRS; logistic regression and ROC curve analysis for diagnostic accuracy; subgroup analysis for IDH status.

Main Results:

  • HGGs demonstrated significantly higher 95th percentile rCBV, Ktrans, and Cho/Cr compared to LGGs (P < 0.01).
  • Areas under the ROC curves (AUC) for differentiating HGGs from LGGs were 0.79 for 95th percentile rCBV and 0.74 for 95th percentile Ktrans.
  • IDH-wildtype glioblastomas and IDH-mutant astrocytomas showed distinct rCBV and Ktrans values, with Ktrans having the highest AUC (0.73) for predicting IDH status.

Conclusions:

  • The 95th percentile of relative cerebral blood volume (rCBV) derived from DSC MRI appears to be the most effective parameter for discriminating between HGGs and LGGs.
  • The 95th percentile of the volume transfer constant (Ktrans) from DCE MRI shows promise in predicting the IDH mutational status of diffuse gliomas.
  • Combined advanced MRI techniques provide valuable insights into glioma grading and molecular subtyping.

Related Concept Videos